Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression AREDS2 report no. 3

JAMA Ophthalmology

Volumn 132, Issue 2, 2014, Pages 142-149

  Chew, Emily Y ^a   Clemons, Traci E ^b   SanGiovanni, John Paul ^c   Danis, Ronald P ^d   Ferris, Frederick L ^c   Elman, Michael J ^e   Antoszyk, Andrew N ^f   Ruby, Alan J ^g   Orth, David ^h   Bressler, Susan B ⁱ   Fish, Gary E ^j   Hubbard, George Baker ^k   Klein, Michael L ^l   Chandra, Suresh R ^m   Blodi, Barbara A ^d,m   Domalpally, Amitha ^m   Friberg, Thomas ⁿ   Wong, Wai T ^c   Rosenfeld, Philip J ^o   Agrón, Elvira ^c   Toth, Cynthia A ^p   Bernstein, Paul S ^q   Sperduto, Robert D ^b   more..

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b EMMES CORPORATION   (United States)

^c NATIONAL EYE INSTITUTE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e Elman Retina Group   (United States)

^f Charlotte Eye Ear Nose and Throat Associates   (United States)

^g WILLIAM BEAUMONT HOSPITAL   (United States)

^h Ingalls Memorial Hospital   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j TEXAS RETINA ASSOCIATES   (United States)

^k EMORY UNIVERSITY   (United States)

^l OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^m UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

ⁿ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^p DUKE UNIVERSITY MEDICAL CENTER   (United States)

^q UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; BETA CAROTENE; DIET; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FATTY ACIDS, OMEGA-3; FEMALE; GEOGRAPHIC ATROPHY; HUMANS; LUTEIN; MALE; MIDDLE AGED; RETINAL DRUSEN; TRACE ELEMENTS; TREATMENT OUTCOME; VISUAL ACUITY; VITAMINS; WET MACULAR DEGENERATION; XANTHOPHYLLS;

EID: 84894229056     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.7376     Document Type: Article

References (36)

1. Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122(4):477-485.
2. Brown DM, Kaiser PK, MichelsM, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432-1444.
3. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 1. Arch Ophthalmol. 2001;119(10):1417-1436
4. Chew EY, Clemons TE, Agrón E, et al; Age-Related Eye Disease Study Research Group. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 3. Ophthalmology. 2013;120(8):1604-1611, e4. Epub 2013 Apr 10
5. SanGiovanni JP, Chew EY, Clemons TE, et al; Age-Related Eye Disease Study Research Group. The relationship of dietary carotenoids, vitamin E, and vitamin C with age-related macular degeneration in a case-control study: AREDS report no. 1. Arch Ophthalmol. 2007;125(9):1225-1232
6. Eye Disease Case-Control Study Group. Antioxidant status and neovascular age-related macular degeneration [published correction appears in Arch Ophthalmol. 1993;111(1):1499]. Arch Ophthalmol. 1993;111(1):104-109.
7. Seddon JM, Ajani UA, Sperduto RD, et al; Eye Disease Case-Control Study Group. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA. 1994;272(18):1413-1420.
8. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. 2001;153(5):424-432.
9. Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CB. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand. 2002;80(4):368-371.
10. Moeller SM, Parekh N, Tinker L, et al; CAREDS Research Study Group. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of theWomen's Health Initiative. Arch Ophthalmol. 2006;124(8):1151-1162.
11. Tan JS,Wang JJ, Flood V, Rochtchina E, SmithW, Mitchell P. Dietary antioxidants and the longer-term incidence of age-related macular degeneration: the Blue-Mountains Eye Study. Ophthalmology. 2008;115(2):334-341.
12. Seddon JM, Rosner B, Sperduto RD, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol. 2001;119(8):1191- 1199.
13. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol. 2003;121(12):1728-1737.
14. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol. 2006;124(7):995-1001.
15. Chua B, Flood V, Rochtchina E,Wang JJ, Smith W, Mitchell P. Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch Ophthalmol. 2006;124(7):981-986.
16. Augood C, Chakravarthy U, Young I, et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr. 2008;88(2): 398-406.
17. Swenor BK, Bressler S, Caulfield L,West SK. The impact of fish and shellfish consumption on age-related macular degeneration. Ophthalmology. 2010;117(12):2395-2401.
18. SanGiovanni JP, Chew EY, Agrón E, et al; Age-Related Eye Disease Study Research Group. The relationship of dietary lipid intake with incident age-related macular degeneration: AREDS report no. 1. Arch Ophthalmol. 2008;126(9):1274-1279
19. SanGiovanni JP, Agrón E, Clemons TE, Chew EY. Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration. Arch Ophthalmol. 2009;127(1):110-112.
20. SanGiovanni JP, Agrón E, Meleth AD, et al; Age-Related Eye Disease Study Research Group. ω-3 Long-chain polyunsaturated fatty acid intake and 12-year incidence of neovascular age-related macular degeneration and central geographic atrophy: a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr. 2009;90(6):1601-1607.
21. Krinsky NI, Johnson EJ. Carotenoid actions and their relation to health and disease. Mol Aspects Med. 2005;26(6):459-516.
22. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19): 2005-2015.
23. Chew EY, Clemons T, SanGiovanni JP, et al; AREDS2 Research Group. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012;119(11):2282-2289.
24. Albanes D, Heinonen OP, Huttunen JK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr. 1995;62(6)(suppl):1427S- 1430S.
25. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996;88(21):1550-1559.
26. Newsome DA, SwartzM, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106(2):192-198.
27. Hambidge M. Underwood Memorial Lecture: human zinc homeostasis: good but not perfect. J Nutr. 2003;113(5)(5, suppl 1):1438S-1442S.
28. Davis MD, Gangnon RE, Lee LY, et al; Age-Related Eye Disease Study Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 1. Arch Ophthalmol. 2005;123(11):1484-1498
29. Wei LJ, Jin DY,Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J AmStat Assoc. 1989;84(408):1065-1073. doi:10.1080 /01621459.1989.10478873.
30. Chew EY, Clemons TE, Agrón E, et al; Age-Related Eye Disease Study Research Group. Ten-year follow-up of age-related macular degeneration in the Age-Related Eye Disease Study: AREDS report no. 1. JAMA Ophthalmol. In press
31. Tan JSL,Mitchell P, Kifley A, Flood V, SmithW, Wang JJ. Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol. 2007;125(8):1089-1095.
32. Tomany SC,Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111(7):1280-1287.
33. Tseng TS, Lin HY, Martin MY, Chen T, Partridge EE. Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey. J Cancer Surviv. 2010;4(4):313-321.
34. Garrett BE, Dube SR, Trosclair A, Caraballo RS, Pechacek TF; Centers for Disease Control and Prevention (CDC). Cigarette smoking: United States, 1965-2008. MMWR Surveill Summ. 2011;60(suppl):109-113.
35. Katz MH. Multivariable Analysis: A Practical Guide For Clinicians. 2nd ed. Cambridge, England: Cambridge University Press; 2006:203.
36. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46.